All News

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

Ref: PR Newswire

Tags: Press Release InventisBio Betta Pharmaceuticals Corporate Affairs D-0502 BPI-D0316 D-0120

ViewPoints: Blueprint putting Ayvakit’s GIST setback in rearview

Ref: ViewPoints Desk

Tags: ViewPoints Blueprint Medicines Novartis FDA Clinical Research (R&D) Marketing & Sales Medical Affairs Ayvakit Rydapt

FDA rejects Aquestive's oral diazepam-based seizure drug Libervant

Ref: Aquestive Therapeutics

Tags: Top Story Aquestive Therapeutics Epilepsy FDA Regulatory Affairs Libervant

COVID-19 vaccine volunteers get second dose to determine validity

Ref: Global Times

Tags: NewsPoints COVID-19 Immunisation Clinical Research (R&D) Medical Affairs Ad5-nCoV

Early Covid Treatments Could Be ‘Bridge’ to Vaccine, Fauci Says

Ref: Bloomberg

Tags: NewsPoints COVID-19 Immunisation Clinical Research (R&D)

407 people injected with mishandled flu vaccines: authorities

Ref: The Korea Herald

Tags: NewsPoints Immunisation Influenza Medical Affairs

Mysuru hospital ready for trials of second vaccine candidate

Ref: The Economic Times

Tags: NewsPoints Novavax COVID-19 Immunisation Clinical Research (R&D)

Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Ref: The Economic Times

Tags: NewsPoints Sun Pharmaceutical Corporate Affairs

Covid Antibodies Endure Over Six Months in China Trial Subjects

Ref: Bloomberg

Tags: NewsPoints AstraZeneca Pfizer Sinovac COVID-19 Immunisation China CDC Clinical Research (R&D)

CECC plans to distribute coronavirus vaccine to 60% of Taiwanese

Ref: Taiwan News

Tags: NewsPoints COVID-19 Immunisation WHO Medical Affairs